FIELD: medicine.
SUBSTANCE: there are described substituted imidazo[2,1-b]thiazoles of general formula 
the R1, R1, R3 R4, M1, M2 radical values are presented in the patent claim cl. 1, as well as methods for making them, drug preparations containing these compounds and application of these compounds for making the drug preparations.
EFFECT: higher efficacy.
23 cl, 3 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED BICYCLIC IMDAZO-3-YLAMINES SUITABLE FOR REGULARING mGluR5-RECEPTOR | 2005 |
|
RU2435770C2 |
| BICYCLIC N-ACYLATED IMIDAZO-3-AMINE OR IMIDAZO-5-AMINE SALTS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2268888C2 |
| ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVES AS mGluR2 ANTAGONISTS | 2006 |
|
RU2412943C2 |
| NOVEL VANILLOID RECEPTOR LIGANDS AND USE THEREOF IN PRODUCING MEDICINAL AGENTS | 2008 |
|
RU2498982C2 |
| BICYCLIC DERIVATIVES OF IMIDAZO-3-YLAMINE, METHOD FOR THEIR PREPARING AND MEDICINAL AGENT BASED ON THEREOF | 2000 |
|
RU2264402C2 |
| INDOLYLALKYLAMINE DERIVATIVES AS 5-HYDROHYTRIPTAMINE-6 LIGANDS | 2002 |
|
RU2309157C2 |
| TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
| ALKYNYL-PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | 2008 |
|
RU2470910C9 |
| NOVEL VANILLOID RECEPTOR LIGANDS AND USE THEREOF IN PRODUCING MEDICINAL AGENTS | 2008 |
|
RU2487120C2 |
| IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2695664C1 |
